These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
523 related articles for article (PubMed ID: 11208710)
1. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Terdiman JP; Gum JR; Conrad PG; Miller GA; Weinberg V; Crawley SC; Levin TR; Reeves C; Schmitt A; Hepburn M; Sleisenger MH; Kim YS Gastroenterology; 2001 Jan; 120(1):21-30. PubMed ID: 11208710 [TBL] [Abstract][Full Text] [Related]
2. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. Piñol V; Castells A; Andreu M; Castellví-Bel S; Alenda C; Llor X; Xicola RM; Rodríguez-Moranta F; Payá A; Jover R; Bessa X; JAMA; 2005 Apr; 293(16):1986-94. PubMed ID: 15855432 [TBL] [Abstract][Full Text] [Related]
3. Genetic testing for hereditary nonpolyposis colorectal cancer. Hoedema R; Monroe T; Bos C; Palmer S; Kim D; Marvin M; Luchtefeld M Am Surg; 2003 May; 69(5):387-91; discussion 391-2. PubMed ID: 12769209 [TBL] [Abstract][Full Text] [Related]
4. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer. Bapat BV; Madlensky L; Temple LK; Hiruki T; Redston M; Baron DL; Xia L; Marcus VA; Soravia C; Mitri A; Shen W; Gryfe R; Berk T; Chodirker BN; Cohen Z; Gallinger S Hum Genet; 1999 Feb; 104(2):167-76. PubMed ID: 10190329 [TBL] [Abstract][Full Text] [Related]
5. MLH1 promoter germline-methylation in selected probands of Chinese hereditary non-polyposis colorectal cancer families. Zhou HH; Yan SY; Zhou XY; Du X; Zhang TM; Cai X; Lu YM; Cai SJ; Shi DR World J Gastroenterol; 2008 Dec; 14(48):7329-34. PubMed ID: 19109866 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Wahlberg SS; Schmeits J; Thomas G; Loda M; Garber J; Syngal S; Kolodner RD; Fox E Cancer Res; 2002 Jun; 62(12):3485-92. PubMed ID: 12067992 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer. Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847 [TBL] [Abstract][Full Text] [Related]
8. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features. Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E Digestion; 2004; 69(3):166-76. PubMed ID: 15118395 [TBL] [Abstract][Full Text] [Related]
9. MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer. Berends MJ; Hollema H; Wu Y; van Der Sluis T; Mensink RG; ten Hoor KA; Sijmons RH; de Vries EG; Pras E; Mourits MJ; Hofstra RM; Buys CH; Kleibeuker JH; van Der Zee AG Int J Cancer; 2001 May; 92(3):398-403. PubMed ID: 11291077 [TBL] [Abstract][Full Text] [Related]
10. Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer. Mangold E; Pagenstecher C; Friedl W; Mathiak M; Buettner R; Engel C; Loeffler M; Holinski-Feder E; Müller-Koch Y; Keller G; Schackert HK; Krüger S; Goecke T; Moeslein G; Kloor M; Gebert J; Kunstmann E; Schulmann K; Rüschoff J; Propping P Int J Cancer; 2005 Sep; 116(5):692-702. PubMed ID: 15849733 [TBL] [Abstract][Full Text] [Related]
11. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer. Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581 [TBL] [Abstract][Full Text] [Related]
12. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test. Mathiak M; Rütten A; Mangold E; Fischer HP; Ruzicka T; Friedl W; Propping P; Kruse R Am J Surg Pathol; 2002 Mar; 26(3):338-43. PubMed ID: 11859205 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain. Caldes T; Godino J; de la Hoya M; Garcia Carbonero I; Perez Segura P; Eng C; Benito M; Diaz-Rubio E Int J Cancer; 2002 Apr; 98(5):774-9. PubMed ID: 11920650 [TBL] [Abstract][Full Text] [Related]
14. Ten novel MSH2 and MLH1 germline mutations in families with HNPCC. Krüger S; Bier A; Plaschke J; Höhl R; Aust DE; Kreuz FR; Pistorius SR; Saeger HD; Rothhammer V; Al-Taie O; Schackert HK Hum Mutat; 2004 Oct; 24(4):351-2. PubMed ID: 15365996 [TBL] [Abstract][Full Text] [Related]
15. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer. Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358 [TBL] [Abstract][Full Text] [Related]
16. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Wu Y; Berends MJ; Mensink RG; Kempinga C; Sijmons RH; van Der Zee AG; Hollema H; Kleibeuker JH; Buys CH; Hofstra RM Am J Hum Genet; 1999 Nov; 65(5):1291-8. PubMed ID: 10521294 [TBL] [Abstract][Full Text] [Related]
17. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306 [TBL] [Abstract][Full Text] [Related]
18. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness. Reyes CM; Allen BA; Terdiman JP; Wilson LS Cancer; 2002 Nov; 95(9):1848-56. PubMed ID: 12404277 [TBL] [Abstract][Full Text] [Related]
19. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016 [TBL] [Abstract][Full Text] [Related]
20. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]